Understanding Choosing New Agents For Itp
Exploring Choosing New Agents For Itp reveals several interesting facts. James B. Bussel, MD, highlights his expectations regarding the future management of idiopathic
Key Takeaways about Choosing New Agents For Itp
- Physicians consider the
- TPO
- James B. Bussel, MD, discusses the mechanism of action for thrombopoietin receptor agonists in the treatment approach of ...
- Ivy Altomare, MD; Terry Gernsheimer, MD; and Keith R. McCrae, MD, further explore the use of corticosteroids in adult idiopathic ...
- Panelists attune the current progress being made in the treatment of immune
Detailed Analysis of Choosing New Agents For Itp
In this video, Hanny Al-Samkari, MD, Massachusetts General Hospital, Boston, MA, briefly discusses treatment Ivy P. Altomare, MD, discusses investigational Hanny Al-Samkari, MD, Massachusetts General Hospital, Boston, MA, highlights exciting developments in treatments for patients ...
Drew Provan, BSc, MBChB, MD, FRCP, FRCPath, Queen Mary University of London, London, UK, gives an overview of novel ...
Stay tuned for more updates related to Choosing New Agents For Itp.
